This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

INR:5106. mascot the school Major new policy: New version of basic clinic standards is here! Winner Medical's annual performance forecast: Net profit exceeds 3 ...

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

In a festive spirit, Elon Musk, the 53-year-old CEO of Tesla and SpaceX, shared a humorous image of himself dressed as Santa ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

The expanding world of GLP-1 agonist medications may be opening unexpected doors in the realm of addiction treatment.

Two SciFri producers discuss the year’s most intriguing stories, from new weight-loss drugs to PFAS chemicals to the ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and scientific acclamation. There are now ...